Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Interactions between the complement and endothelin systems in normal pregnancy and following placental ischemia.

Regal JF, Lund JM, Wing CR, Root KM, McCutcheon L, Bemis LT, Gilbert JS, Fleming SD.

Mol Immunol. 2019 Oct;114:10-18. doi: 10.1016/j.molimm.2019.06.015. Epub 2019 Jul 18.

PMID:
31326653
2.

Irritability uniquely predicts prefrontal cortex activation during preschool inhibitory control among all temperament domains: A LASSO approach.

Fishburn FA, Hlutkowsky CO, Bemis LM, Huppert TJ, Wakschlag LS, Perlman SB.

Neuroimage. 2019 Jan 1;184:68-77. doi: 10.1016/j.neuroimage.2018.09.023. Epub 2018 Sep 11.

PMID:
30213776
3.

miRNA-regulated transcription associated with mouse strains predisposed to hypnotic effects of ethanol.

Vestal B, Russell P, Radcliffe RA, Bemis L, Saba LM, Kechris K.

Brain Behav. 2018 Jun;8(6):e00989. doi: 10.1002/brb3.989. Epub 2018 Apr 30.

4.

Putting our heads together: interpersonal neural synchronization as a biological mechanism for shared intentionality.

Fishburn FA, Murty VP, Hlutkowsky CO, MacGillivray CE, Bemis LM, Murphy ME, Huppert TJ, Perlman SB.

Soc Cogn Affect Neurosci. 2018 Sep 5;13(8):841-849. doi: 10.1093/scan/nsy060.

5.

Mycobacterium tuberculosis Pst/SenX3-RegX3 Regulates Membrane Vesicle Production Independently of ESX-5 Activity.

White DW, Elliott SR, Odean E, Bemis LT, Tischler AD.

MBio. 2018 Jun 12;9(3). pii: e00778-18. doi: 10.1128/mBio.00778-18.

6.

Using facial muscular movements to understand young children's emotion regulation and concurrent neural activation.

Grabell AS, Huppert TJ, Fishburn FA, Li Y, Jones HM, Wilett AE, Bemis LM, Perlman SB.

Dev Sci. 2018 Sep;21(5):e12628. doi: 10.1111/desc.12628. Epub 2017 Dec 11.

7.

A tRNA fragment, tRF5-Glu, regulates BCAR3 expression and proliferation in ovarian cancer cells.

Zhou K, Diebel KW, Holy J, Skildum A, Odean E, Hicks DA, Schotl B, Abrahante JE, Spillman MA, Bemis LT.

Oncotarget. 2017 Sep 8;8(56):95377-95391. doi: 10.18632/oncotarget.20709. eCollection 2017 Nov 10.

8.

A method for extracting and characterizing RNA from urine: For downstream PCR and RNAseq analysis.

Zhou K, Spillman MA, Behbakht K, Komatsu JM, Abrahante JE, Hicks D, Schotl B, Odean E, Jones KL, Graner MW, Bemis LT.

Anal Biochem. 2017 Nov 1;536:8-15. doi: 10.1016/j.ab.2017.08.003. Epub 2017 Aug 10.

9.

HSP90 inhibitors in the context of heat shock and the unfolded protein response: effects on a primary canine pulmonary adenocarcinoma cell line.

Graner AN, Hellwinkel JE, Lencioni AM, Madsen HJ, Harland TA, Marchando P, Nguyen GJ, Wang M, Russell LM, Bemis LT, Anchordoquy TJ, Graner MW.

Int J Hyperthermia. 2017 May;33(3):303-317. doi: 10.1080/02656736.2016.1256503. Epub 2016 Dec 20.

10.

Role of IgM and angiotensin II Type I receptor autoantibodies in local complement activation in placental ischemia-induced hypertension in the rat.

Regal JF, Strehlke ME, Peterson JM, Wing CR, Parker JE, Nieto NF, Bemis LT, Gilbert JS, Fleming SD.

Mol Immunol. 2016 Oct;78:38-47. doi: 10.1016/j.molimm.2016.08.016. Epub 2016 Aug 30.

11.

DNA methylation in a sea lamprey vasotocin receptor gene promoter correlates with tissue- and life-stage-specific mRNA expression.

Mayasich SA, Bemis LT, Clarke BL.

Comp Biochem Physiol B Biochem Mol Biol. 2016 Dec;202:56-66. doi: 10.1016/j.cbpb.2016.07.007. Epub 2016 Aug 4.

PMID:
27497665
12.

A method to distinguish morphologically similar Peromyscus species using extracellular RNA and high-resolution melt analysis.

Seifert VA, Clarke BL, Crossland JP, Bemis LT.

Anal Biochem. 2016 Sep 1;508:65-72. doi: 10.1016/j.ab.2016.06.022. Epub 2016 Jun 24.

PMID:
27349513
13.

Beyond the Ribosome: Extra-translational Functions of tRNA Fragments.

Diebel KW, Zhou K, Clarke AB, Bemis LT.

Biomark Insights. 2016 Jan 28;11(Suppl 1):1-8. doi: 10.4137/BMI.S35904. eCollection 2016. Review.

14.

Improving medical students' knowledge of genetic disease: a review of current and emerging pedagogical practices.

Wolyniak MJ, Bemis LT, Prunuske AJ.

Adv Med Educ Pract. 2015 Oct 29;6:597-607. doi: 10.2147/AMEP.S73644. eCollection 2015. Review.

15.

Identification of heat shock protein 10 within the equine embryo, endometrium, and maternal peripheral blood mononuclear cells.

Hatzel JN, Bouma GJ, Cleys ER, Bemis LT, Ehrhart EJ, McCue PM.

Theriogenology. 2015 Mar 15;83(5):832-9. doi: 10.1016/j.theriogenology.2014.11.020. Epub 2014 Nov 26.

PMID:
25542459
16.

The multiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associations.

Ru Y, Kechris KJ, Tabakoff B, Hoffman P, Radcliffe RA, Bowler R, Mahaffey S, Rossi S, Calin GA, Bemis L, Theodorescu D.

Nucleic Acids Res. 2014;42(17):e133. doi: 10.1093/nar/gku631. Epub 2014 Jul 24.

17.

Pediatric brainstem gangliogliomas show BRAF(V600E) mutation in a high percentage of cases.

Donson AM, Kleinschmidt-DeMasters BK, Aisner DL, Bemis LT, Birks DK, Levy JM, Smith AA, Handler MH, Foreman NK, Rush SZ.

Brain Pathol. 2014 Mar;24(2):173-83. doi: 10.1111/bpa.12103. Epub 2013 Dec 23.

18.

miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma.

Bennett PE, Bemis L, Norris DA, Shellman YG.

Physiol Genomics. 2013 Nov 15;45(22):1049-59. doi: 10.1152/physiolgenomics.00116.2013. Epub 2013 Sep 17. Review.

19.

Standardization of sample collection, isolation and analysis methods in extracellular vesicle research.

Witwer KW, Buzás EI, Bemis LT, Bora A, Lässer C, Lötvall J, Nolte-'t Hoen EN, Piper MG, Sivaraman S, Skog J, Théry C, Wauben MH, Hochberg F.

J Extracell Vesicles. 2013 May 27;2. doi: 10.3402/jev.v2i0.20360. eCollection 2013.

20.

Prolonged remission of advanced bronchoalveolar adenocarcinoma in a dog treated with autologous, tumour-derived chaperone-rich cell lysate (CRCL) vaccine.

Epple LM, Bemis LT, Cavanaugh RP, Skope A, Mayer-Sonnenfeld T, Frank C, Olver CS, Lencioni AM, Dusto NL, Tal A, Har-Noy M, Lillehei KO, Katsanis E, Graner MW.

Int J Hyperthermia. 2013 Aug;29(5):390-8. doi: 10.3109/02656736.2013.800997. Epub 2013 Jun 20.

PMID:
23786302
21.

miR-125b Regulation of Androgen Receptor Signaling Via Modulation of the Receptor Complex Co-Repressor NCOR2.

Yang X, Bemis L, Su LJ, Gao D, Flaig TW.

Biores Open Access. 2012 Apr;1(2):55-62. doi: 10.1089/biores.2012.9903.

22.

MicroRNA-26a is strongly downregulated in melanoma and induces cell death through repression of silencer of death domains (SODD).

Reuland SN, Smith SM, Bemis LT, Goldstein NB, Almeida AR, Partyka KA, Marquez VE, Zhang Q, Norris DA, Shellman YG.

J Invest Dermatol. 2013 May;133(5):1286-93. doi: 10.1038/jid.2012.400. Epub 2012 Nov 29.

23.

Need for rigor in design, reporting, and interpretation of transcriptomic biomarker studies.

Walter ND, Bemis L, Edwards M, Ovrutsky AR, Chan ED.

J Clin Microbiol. 2012 Dec;50(12):4190-1; discussion 4192-3. doi: 10.1128/JCM.06775-11. No abstract available.

24.

Medulloblastoma exosome proteomics yield functional roles for extracellular vesicles.

Epple LM, Griffiths SG, Dechkovskaia AM, Dusto NL, White J, Ouellette RJ, Anchordoquy TJ, Bemis LT, Graner MW.

PLoS One. 2012;7(7):e42064. doi: 10.1371/journal.pone.0042064. Epub 2012 Jul 27.

25.

Clinical and molecular characteristics of congenital glioblastoma.

Macy ME, Birks DK, Barton VN, Chan MH, Donson AM, Kleinschmidt-Demasters BK, Bemis LT, Handler MH, Foreman NK.

Neuro Oncol. 2012 Jul;14(7):931-41. doi: 10.1093/neuonc/nos125. Epub 2012 Jun 18.

26.

Common PIK3CA mutants and a novel 3' UTR mutation are associated with increased sensitivity to saracatinib.

Arcaroli JJ, Quackenbush KS, Powell RW, Pitts TM, Spreafico A, Varella-Garcia M, Bemis L, Tan AC, Reinemann JM, Touban BM, Dasari A, Eckhardt SG, Messersmith WA.

Clin Cancer Res. 2012 May 1;18(9):2704-14. doi: 10.1158/1078-0432.CCR-11-3167.

27.

MIR29B regulates expression of MLLT11 (AF1Q), an MLL fusion partner, and low MIR29B expression associates with adverse cytogenetics and poor overall survival in AML.

Xiong Y, Li Z, Ji M, Tan AC, Bemis J, Tse JV, Huang G, Park J, Ji C, Chen J, Bemis LT, Bunting KD, Tse W.

Br J Haematol. 2011 Jun;153(6):753-7. doi: 10.1111/j.1365-2141.2011.08662.x. Epub 2011 Apr 18.

28.

Recovery of MicroRNA from Stored Human Peripheral Blood Samples.

Seelenfreund E, Robinson SE, Amato CM, Bemis LT, Robinson WA.

Biopreserv Biobank. 2011 Mar;9(1):29-33. doi: 10.1089/bio.2010.0026. Epub 2011 Mar 21.

PMID:
24850203
29.

MicroRNA-137 targets carboxyl-terminal binding protein 1 in melanoma cell lines.

Deng Y, Deng H, Bi F, Liu J, Bemis LT, Norris D, Wang XJ, Zhang Q.

Int J Biol Sci. 2011 Jan 27;7(1):133-7.

30.

MiR-886-3p down regulates CXCL12 (SDF1) expression in human marrow stromal cells.

Pillai MM, Yang X, Balakrishnan I, Bemis L, Torok-Storb B.

PLoS One. 2010 Dec 13;5(12):e14304. doi: 10.1371/journal.pone.0014304.

31.

KRAS mutation: comparison of testing methods and tissue sampling techniques in colon cancer.

Franklin WA, Haney J, Sugita M, Bemis L, Jimeno A, Messersmith WA.

J Mol Diagn. 2010 Jan;12(1):43-50. doi: 10.2353/jmoldx.2010.080131. Epub 2009 Dec 10.

32.

Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with vandetanib sensitizes bladder cancer cells to cisplatin in a dose- and sequence-dependent manner.

Flaig TW, Su LJ, McCoach C, Li Y, Raben D, Varella-Garcia M, Bemis LT.

BJU Int. 2009 Jun;103(12):1729-37. doi: 10.1111/j.1464-410X.2009.08367.x. Epub 2009 Feb 10.

33.

Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma.

Chen RW, Bemis LT, Amato CM, Myint H, Tran H, Birks DK, Eckhardt SG, Robinson WA.

Blood. 2008 Aug 1;112(3):822-9. doi: 10.1182/blood-2008-03-142182. Epub 2008 May 15.

34.

MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines.

Bemis LT, Chen R, Amato CM, Classen EH, Robinson SE, Coffey DG, Erickson PF, Shellman YG, Robinson WA.

Cancer Res. 2008 Mar 1;68(5):1362-8. doi: 10.1158/0008-5472.CAN-07-2912.

35.

EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines.

Weiss GJ, Bemis LT, Nakajima E, Sugita M, Birks DK, Robinson WA, Varella-Garcia M, Bunn PA Jr, Haney J, Helfrich BA, Kato H, Hirsch FR, Franklin WA.

Ann Oncol. 2008 Jun;19(6):1053-9. doi: 10.1093/annonc/mdn006. Epub 2008 Feb 27.

PMID:
18304967
36.

EGFR-mutant lung adenocarcinoma in a patient with Li-Fraumeni syndrome.

Bemis LT, Robinson WA, McFarlane R, Buyers E, Kelly K, Varella-Garcia M, Mitchell JD, Franklin WA.

Lancet Oncol. 2007 Jun;8(6):559-60. No abstract available.

PMID:
17540308
37.

Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib.

Hirsch FR, Varella-Garcia M, Cappuzzo F, McCoy J, Bemis L, Xavier AC, Dziadziuszko R, Gumerlock P, Chansky K, West H, Gazdar AF, Crino L, Gandara DR, Franklin WA, Bunn PA Jr.

Ann Oncol. 2007 Apr;18(4):752-60. Epub 2007 Feb 22.

PMID:
17317677
38.

Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels.

Helfrich BA, Raben D, Varella-Garcia M, Gustafson D, Chan DC, Bemis L, Coldren C, Barón A, Zeng C, Franklin WA, Hirsch FR, Gazdar A, Minna J, Bunn PA Jr.

Clin Cancer Res. 2006 Dec 1;12(23):7117-25.

39.

An evolutionary model for identifying genetic adaptation to high altitude.

Moore LG, Shriver M, Bemis L, Vargas E.

Adv Exp Med Biol. 2006;588:101-18.

PMID:
17089883
40.

HER2 mutation and response to trastuzumab therapy in non-small-cell lung cancer.

Cappuzzo F, Bemis L, Varella-Garcia M.

N Engl J Med. 2006 Jun 15;354(24):2619-21. No abstract available.

PMID:
16775247
41.

HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients.

Cappuzzo F, Toschi L, Domenichini I, Bartolini S, Ceresoli GL, Rossi E, Ludovini V, Cancellieri A, Magrini E, Bemis L, Franklin WA, Crino L, Bunn PA Jr, Hirsch FR, Varella-Garcia M.

Br J Cancer. 2005 Dec 12;93(12):1334-40.

42.

C-kit expression in dedifferentiated and well-differentiated liposarcomas; immunohistochemistry and genetic analysis.

Tayal S, Classen E, Bemis L, Robinson WA.

Anticancer Res. 2005 May-Jun;25(3B):2215-20.

43.

The use of an electronic audience response system for data collection.

Gamito EJ, Burhansstipanov L, Krebs LU, Bemis L, Bradley A.

J Cancer Educ. 2005 Spring;20(1 Suppl):80-6.

PMID:
15916526
44.

Sample genetic policy language for research conducted with native communities.

Burhansstipanov L, Bemis L, Kaur JS, Bemis G.

J Cancer Educ. 2005 Spring;20(1 Suppl):52-7.

PMID:
15916522
45.

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer.

Cappuzzo F, Hirsch FR, Rossi E, Bartolini S, Ceresoli GL, Bemis L, Haney J, Witta S, Danenberg K, Domenichini I, Ludovini V, Magrini E, Gregorc V, Doglioni C, Sidoni A, Tonato M, Franklin WA, Crino L, Bunn PA Jr, Varella-Garcia M.

J Natl Cancer Inst. 2005 May 4;97(9):643-55.

PMID:
15870435
46.
47.

Native American recommendations for genetic research to be culturally respectful.

Burhansstipanov L, Bemis LT, Dignan M.

Jurimetrics. 2002 Winter;42(2):149-57.

PMID:
15119329
48.

Distinct aerobic and hypoxic mechanisms of HIF-alpha regulation by CSN5.

Bemis L, Chan DA, Finkielstein CV, Qi L, Sutphin PD, Chen X, Stenmark K, Giaccia AJ, Zundel W.

Genes Dev. 2004 Apr 1;18(7):739-44.

49.

Maternal adaptation to high-altitude pregnancy: an experiment of nature--a review.

Moore LG, Shriver M, Bemis L, Hickler B, Wilson M, Brutsaert T, Parra E, Vargas E.

Placenta. 2004 Apr;25 Suppl A:S60-71. Review.

PMID:
15033310
50.

WNT7a induces E-cadherin in lung cancer cells.

Ohira T, Gemmill RM, Ferguson K, Kusy S, Roche J, Brambilla E, Zeng C, Baron A, Bemis L, Erickson P, Wilder E, Rustgi A, Kitajewski J, Gabrielson E, Bremnes R, Franklin W, Drabkin HA.

Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10429-34. Epub 2003 Aug 22.

Supplemental Content

Support Center